Sixth Framework Programme

Sixth Framework Programme. The Sixth Framework Programme for Research and Technological Development was the European Union's main instrument for funding collaborative scientific research and development from 2002 to 2006. With a budget of €17.5 billion, it aimed to strengthen the European Research Area by integrating scientific resources and fostering innovation across member states and associated countries. The programme focused on structuring European research around key thematic priorities and promoting greater cohesion in the continent's scientific efforts.

Overview

The programme was established under a specific decision by the European Parliament and the Council of the European Union, building upon the legacy of the preceding Fifth Framework Programme. Its launch coincided with the enlargement of the European Union in 2004, which brought in new member states like Poland, Hungary, and the Czech Republic. The overarching goal was to contribute to the creation of the European Research Area, a concept championed by the European Commission to create a unified market for research. Key figures in its development included European Commissioners such as Philippe Busquin and later Janez Potočnik.

Structure and priorities

The structure was organized around three main blocks, with the majority of funding directed toward seven thematic priority areas. These focused areas included life sciences and biotechnology, information society technologies, and sustainable development. Significant emphasis was placed on integrating research capacities, with dedicated support for structuring the European Research Area through initiatives like research infrastructure development. Another major component was strengthening the foundations of the European Research Area, which involved coordinating national research programmes and supporting regional research-driven clusters. A specific priority was given to research related to Euratom for nuclear activities.

Implementation and instruments

To achieve its objectives, it introduced new legal and financial instruments designed for large-scale integration. The most notable was the Network of Excellence, intended to foster long-term collaboration between research institutions across Europe. Another key instrument was the Integrated Project, which mobilized critical masses of resources to achieve ambitious scientific goals. Funding was also allocated through specific targeted research projects and coordination actions. Management of these instruments was overseen by the European Commission's Directorate-General for Research, with implementation support from executive agencies. Calls for proposals were published regularly, and evaluation was conducted with the assistance of independent experts from academia and industry.

Participation and impact

Participation was open to entities from European Union member states, associated countries like Switzerland and Israel, and international partners. It successfully mobilized hundreds of thousands of researchers from thousands of institutions, including major universities, public research bodies like the CNRS, and industrial partners such as Nokia and GlaxoSmithKline. The programme funded pioneering work in fields like nanotechnology, genomics, and aerospace, contributing to projects that later fed into initiatives like Galileo. It played a crucial role in building pan-European scientific networks and helped prepare the ground for the more ambitious Seventh Framework Programme.

Criticism and evaluation

Despite its achievements, the programme faced criticism for its complex administrative procedures and bureaucratic overhead, which were seen as burdensome for participants. Evaluations, including those by the European Court of Auditors, pointed to challenges in measuring the tangible economic impact of the funded research. Some analysts argued that the new instruments, like the Network of Excellence, were not always effective in achieving lasting integration. The mid-term review conducted by the European Commission acknowledged these issues and led to simplifications in certain processes. Comparisons were often made with research funding systems in the United States, particularly the National Institutes of Health and the National Science Foundation, highlighting differences in flexibility and risk-taking.

Category:European Union research programmes